The laboratory proficiency testing market size was valued at USD 1.50 billion in 2022, and is projected to reach USD 2.85 billion by 2031, with a CAGR of 7.4% from 2023 – 2031. The growth of the market is attributed to the increase in emphasis on diagnostic laboratories, laboratory proficiency testing due to the COVID-19 pandemic. Proficiency testing ensures that the tests used to diagnose the novel coronavirus are correctly interpreted, processed, and administered, resulting in high precision and trust in the results.
Proficiency testing is critical in all pandemic-affected areas. Various organizations are launching programs to help laboratories overcome accreditation barriers, thereby fueling the market. For example, in November 2020, the World Health Organization (WHO) collaborated with the Department of Health (DOH) and government entities to provide training and ensure the establishment and certification of testing laboratories.
Foodborne disease outbreaks are expected to increase due to the rising ingestion of contaminated foods that contain bacteria, viruses, chemical substances, and parasites. According to the WHO, nearly 600 million people, or about one out of every 10 people, worldwide contract illnesses by consuming contaminated food, resulting in 420,000 deaths every year. More than 200 diseases, including diarrhea and cancer, can be caused by food pollutants.
Laboratory Proficiency Testing Market Trends, Drivers, Restraints, and Opportunities:
-
Increasing number of proficiency training programs introduced by key players is expected to boost the market.
-
Introduction of regulations to test potency and pollutants is expected to drive the market.
-
As the market for high-potency cannabis grows, laboratories that provide assays have sprung up to meet the demand is expected to boost market.
Scope of the Report
The report on the laboratory proficiency testing market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Laboratory Proficiency Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Industry Scope (Clinical Diagnostics[Clinical Chemistry, Immunochemistry, Hematology, Oncology, Molecular Diagnostics {PCR, and Others}, Coagulation], Pharmaceuticals [Biologics {Vaccines, Blood, and Tissues}, and Others], and Microbiology [Pathogen Testing, Sterility Testing, Endotoxin & Pyrogen Testing, Growth Promotion Testing, and Other Microbial Testing], and Others), Technology (Cell Culture, Spectrometry, Polymerase Chain Reaction (PCR), Chromatography, Immunoassays, and Others), End Use (Hospitals, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Academic Research, and Diagnostic Laboratories [Independent Laboratories, and Specialty Laboratories])
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
LGC Limited; American Proficiency Institute; College of American Pathologists; Bio-Rad Laboratories, Inc.; Randox Laboratories Ltd.; QACS - The Challenge Test Laboratory; Merck & Co., Inc.; Weqas; ERA; AOAC International; BIPEA; NSI Lab Solutions; Absolute Standards, Inc.; RCPA; UK NEQAS; INSTAND
|
Laboratory Proficiency TestingMarket Segment Insights:
Immunochemistry segment accounted for key share
Based on industry scope, the global laboratory proficiency testing market is divided into clinical diagnostics, pharmaceuticals, microbiology, and others. The clinical diagnostics segment is further divided into clinical chemistry, immunochemistry, hematology, oncology, molecular diagnostics, and coagulation. The molecular diagnostics segment is bifurcated into PCR and others.
The pharmaceuticals segment is segregated into biologics and others. The biologics segment is sub-segmented into vaccines, blood, and tissues. Similarly, the microbiology segment is classified as pathogen testing, sterility testing, endotoxin & pyrogen testing, growth promotion testing, and other microbial testing.
The immunochemistry segment accounts for a key share of the market. The clinical diagnostics segment accounted for the highest share, in terms of sales in 2020 due to advancements in complex diagnostic tests and high demand for early detection. Proficiency testing can help clinical diagnostics increase their performance, reproducibility, and accuracy.
The immunochemistry segment held a significant share of the market in 2020 due to its high for testing allergies, autoimmune disorders, hormones, infectious diseases, serum electrophoresis, urine electrophoresis, and immunoglobulin. Quality control laboratories in the pharmaceutical industry play a critical role in monitoring the quality of drugs that are about to be launched in the market.
Cell culture segment accounted for highest revenue share
On the basis of technology, the global laboratory proficiency testing market is divided into cell culture, spectrometry, polymerase chain reaction (PCR), chromatography, immunoassays, and others. The cell culture segment constituted a key share of the market in 2020. Its use in diagnosing the presence of infectious microorganisms in the blood is expected to drive the segment in the coming years.
In the pharmaceutical industry, experiments are used to assess the efficacy of vaccines and cell culture-based products. Increase in use of cell culture experiments to gain microbial strain cultures has coincided with the increase in use of cell culture-based products such as monoclonal antibodies. Proficiency tests are available to assess laboratory efficiency and search for contaminants and impurities in cell cultures.
Hospital segment accounted for highest revenue share
In terms of end-use, the global laboratory proficiency testing market is classified as hospitals, contract research organizations, pharmaceutical & biotechnology companies, academic research, and diagnostic laboratories. The diagnostics laboratories segment is further divided into independent laboratories and specialty laboratories.
In 2020, the hospitals segment held a key share of the market. The diagnostic laboratories segment is anticipated to expand at a rapid pace during the forecast period due to high preference among patients. These laboratories offer a wide variety of tests in a short amount of time, which is a competitive advantage. Pharmaceutical and biotechnology firms are big manufacturing and research & development centers.
Pharmaceutical and biotechnology companies use proficiency testing services to ensure testing accuracy and verify laboratory efficacy. This helps companies to change processes that are not in-line with the regulatory guidelines, ensuring the final product's quality for FDA approval.
The contract research organizations segment is expected to expand significantly during the forecast period. CROs are primarily based in emerging economies such as India and China. CROs are likely to extend the scope of laboratory proficiency testing, as stringent FDA requirements for R&D and clinical trials are being implemented.
Asia Pacific is a fast-growing market
In terms of regions, the global laboratory proficiency testing market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a dominant share of the market in 2020 and this trend is projected to continue during the forecast period, as several governments and regulatory bodies are implementing rigid regulatory framework to increase testing proficiency.
Furthermore, the presence of major players in the US is expected to boost the market in the region. The market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. The market is expected to expand due to increasing healthcare awareness and rising number of laboratories seeking international accreditation.
Segments
The global laboratory proficiency testing market has been segmented on the basis of
Industry scope
- Clinical Chemistry
- Immunochemistry
- Hematology
- Oncology
- Molecular Diagnostics
- PCR
- Others
- Coagulation
- Pharmaceuticals
- Biologics
- Vaccines
- Blood
- Tissues
- Others
- Pathogen Testing
- Sterility Testing
- Endotoxin & Pyrogen Testing
- Growth Promotion Testing
- Other Microbial Testing
Technology
- Cell Culture
- Spectrometry
- Polymerase Chain Reaction (PCR)
- Chromatography
- Immunoassays
- Others
End use
- Hospitals
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- Academic Research
- Diagnostic Laboratories
- Independent Laboratories
- Specialty Laboratories
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- LGC Limited
- American Proficiency Institute
- College of American Pathologists
- Bio-Rad Laboratories, Inc.
- Randox Laboratories Ltd.
- QACS - The Challenge Test Laboratory
- Merck & Co., Inc.
- Weqas
- ERA
- AOAC International
- BIPEA
- NSI Lab Solutions
- Absolute Standards, Inc.
- RCPA
- UK NEQAS
- INSTAND
Competitive Landscape
Major players in the market include LGC Limited; American Proficiency Institute; College of American Pathologists; Bio-Rad Laboratories, Inc.; Randox Laboratories Ltd.; QACS - The Challenge Test Laboratory; Merck & Co., Inc.; Weqas; ERA; AOAC International; BIPEA; NSI Lab Solutions; Absolute Standards, Inc.; RCPA; UK NEQAS; INSTAND. They engage in partnerships and mergers & acquisitions to expand their product portfolios, manufacturing capabilities, and provide competitive differentiation.
In October 2020, the Abu Dhabi Quality & Conformity Council's Central Testing Laboratory, in collaboration with Biogenix Lab, launched a proficiency testing program to verify the competency of medical laboratories performing COVID-19 tests. The demand for proficiency testing increased dramatically during the SARS-CoV-2 pandemic.
Request For Customization
Enquiry Before Buying
Speak With Analyst
